Ik moest poma en biabs googelen.
Wie ben jij?
😂
Wie ben jij?
😂
June 25, 2025 at 8:28 PM
Ik moest poma en biabs googelen.
Wie ben jij?
😂
Wie ben jij?
😂
CART cells & bispecific mAbs in myeloma.
'However, in our experience, while the PFS was similar with the two approaches, CART therapy resulted in better OS, mainly because of the efficacy of BiAbs as rescue therapy. Our results highlight the importance of treatment sequence in real-word experience'
'However, in our experience, while the PFS was similar with the two approaches, CART therapy resulted in better OS, mainly because of the efficacy of BiAbs as rescue therapy. Our results highlight the importance of treatment sequence in real-word experience'
A research center’s experience of T-cell redirecting therapies in triple-class refractory multiple myeloma
The efficacies of chimeric antigen receptor T (CAR-T) cells and bispecific monoclonal antibodies (BiAbs) for triple-class refractory (TCR) myeloma hav…
www.sciencedirect.com
June 19, 2024 at 6:53 PM
CART cells & bispecific mAbs in myeloma.
'However, in our experience, while the PFS was similar with the two approaches, CART therapy resulted in better OS, mainly because of the efficacy of BiAbs as rescue therapy. Our results highlight the importance of treatment sequence in real-word experience'
'However, in our experience, while the PFS was similar with the two approaches, CART therapy resulted in better OS, mainly because of the efficacy of BiAbs as rescue therapy. Our results highlight the importance of treatment sequence in real-word experience'
Niet klagen als ze vervolgens 45 euro vragen voor een portie Lapsang Souchong-wentelteefjes en een virgin poma bij je Biabs.
June 25, 2025 at 2:22 PM
Niet klagen als ze vervolgens 45 euro vragen voor een portie Lapsang Souchong-wentelteefjes en een virgin poma bij je Biabs.
les biabs......
June 26, 2025 at 5:45 AM
les biabs......
🤖 Broad reactivity and enhanced potency of recombinant anti-EGFR × anti-CD3 bispecific antibody-armed activated T cells against solid tumours.
Annals of medicine(2022)
#Biotechnology #Science
Annals of medicine(2022)
#Biotechnology #Science
Broad reactivity and enhanced potency of recombinant anti-EGFR × anti-CD3 bispecific antibody-armed activated T cells against solid tumours - PubMed
<span><b>Introduction:</b> Bispecific antibody (BiAb)-armed activated T cells (BATs) comprise an adoptive T cell therapy platform for treating cancer. Arming activated T cells (ATC) with anti-CD3 x anti-tumour associated antigen (TAA) BiAbs converts ATC into non-major histocompatibility complex (MHC)-rest</span> …
pubmed.ncbi.nlm.nih.gov
April 21, 2026 at 2:08 AM
🤖 Broad reactivity and enhanced potency of recombinant anti-EGFR × anti-CD3 bispecific antibody-armed activated T cells against solid tumours.
Annals of medicine(2022)
#Biotechnology #Science
Annals of medicine(2022)
#Biotechnology #Science